Active · per the CBE, 30 October 2026
REPROBIOL logo

REPROBIOL

BE0886862189

Rechtspersoon Private limited company 1 establishment

REPROBIOL is registered with the CBE as active in: Vervaardiging van farmaceutische grondstoffen. Private Limited, started on 31 January 2007, 1 establishment.

Rue Pelé-Bois 20, 4590 Ouffet reprobiol.be 086477333 [email protected]

Behind the company: Benoit GLAUDE.

Active for

19 year, 8 months

Financials

Financial year 2025

REPROBIOL from Ouffet, company number BE0886862189, closed financial year 2025 with a result of € 71,400 after tax. For that financial year REPROBIOL recorded a gross margin of € 479,821 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 95,318 to € 71,400. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 20, 2026.

What it is worth Healthy

€ 1.5 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 71,400

▼ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 650,344

▲ 90% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 75,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

5.8

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 281,151

▼ 4% vs 2024

€ 48,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,384

▲ 146% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go

€ 193,485

▼ 17% vs 2024

€ 39,126 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 131,895

▲ 247% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 23,893

▼ 25% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 503,118 € 604,210 € 504,975 € 479,821 ▼ 5%
Profit after taxes € 216,835 € 230,435 € 95,318 € 71,400 ▼ 25%
Equity € 1,230,151 € 1,438,290 € 1,511,313 € 1,505,418
Total debts € 515,373 € 697,046 € 322,356 € 425,138 ▲ 32%
Cash € 571,865 € 440,745 € 342,878 € 650,344 ▲ 90%
Land & buildings € 534,969 € 623,457 € 702,586 € 655,548 ▼ 7%
Retained profit € 1,160,437 € 1,370,871 € 1,446,190 € 1,442,590
Dividend € 20,000 € 20,000 € 20,000 € 75,000 ▲ 275%
Bank debt € 312,148 € 269,284 € 231,788 € 193,485 ▼ 17%
Balance sheet total € 1,745,524 € 2,135,336 € 1,833,669 € 1,930,556 ▲ 5%
Employees (FTE) - 4.9 5.6 5.8 ▲ 0.2

Key figures of REPROBIOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to REPROBIOL?

What happened at REPROBIOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 71,400 (▼ 25% vs 2024). Source: NBB ↗
  • Benoit GLAUDE became a director. NBB
  • New establishment in Ouffet. KBO
  • Start of the company according to the CBE. KBO

In short

From € 216,835 profit in 2022 to € 71,400 profit in 2025.

Paid € 197,771 in corporate taxes since 2022.

Best year ever: 2023, with € 230,435 profit.

On average € 82,700 of value added per employee in 2025.

Management

GenomiX 62%

The stake of GenomiX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

REPROBIOL

Behind REPROBIOL is Benoit GLAUDE. The shares are held by GenomiX (62%).

Directors

According to the 2025 annual accounts

Benoit GLAUDE

Director

Also active at: GenomiX, BIO-MIX

since 2023

Shareholders

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Pelé-Bois 20

4590 Ouffet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Advanced Custom FieldsLodashPWAReactWixlazysizes

Hosting & Email

Email provider

OVH Mail

Hosting

WIX_COM, IL

DNS

OVH DNS

Website info

HTTPS Ja
Languages EN, FR, NL
Copyright 2025

Features

Security

✓ HTTPS
✓ SPF
✗ DMARC

Details

Company number
0886.862.189
VAT number
BE 0886.862.189
Registered office
Rue Pelé-Bois 20, 4590 Ouffet
Names & denominations
REPROBIOL
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
31 January 2007
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Vervaardiging van farmaceutische grondstoffen

Detailhandel in farmaceutische producten

Vervaardiging van geneesmiddelen

Frequently asked questions

What does REPROBIOL do?
REPROBIOL is registered with the CBE as active in: Vervaardiging van farmaceutische grondstoffen. Private Limited, started on 31 January 2007, 1 establishment.
What is the address of REPROBIOL?
The registered office of REPROBIOL is located at Rue Pelé-Bois 20, 4590 Ouffet.
Is REPROBIOL still active?
Yes. According to the CBE (30 October 2026) REPROBIOL is active, legal situation “Normale toestand”, started on 31 January 2007.
Is REPROBIOL registered on Peppol?
Yes, REPROBIOL is registered on the Peppol network with ID 0208:0886862189.
What is the enterprise number of REPROBIOL?
The enterprise number of REPROBIOL is BE0886862189.
When was REPROBIOL founded?
REPROBIOL was founded on 31 January 2007.